BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24365195)

  • 1. Levels of circulating CD34+/KDR+ cells do not predict coronary in-stent restenosis.
    Haine SE; Van Craenenbroeck EM; Hoymans VY; Miljoen HP; Vandendriessche TR; Claeys MJ; Frederix G; Conraads VM; Bosmans JM; Vrints CJ
    Can J Cardiol; 2014 Jan; 30(1):102-8. PubMed ID: 24365195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
    Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
    Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis.
    Inoue T; Sata M; Hikichi Y; Sohma R; Fukuda D; Uchida T; Shimizu M; Komoda H; Node K
    Circulation; 2007 Feb; 115(5):553-61. PubMed ID: 17261663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study.
    Pelliccia F; Cianfrocca C; Rosano G; Mercuro G; Speciale G; Pasceri V
    JACC Cardiovasc Interv; 2010 Jan; 3(1):78-86. PubMed ID: 20129574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina.
    Surdacki A; Marewicz E; Wieteska E; Szastak G; Rakowski T; Wieczorek-Surdacka E; Dudek D; Pryjma J; Dubiel JS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2265-73. PubMed ID: 18187495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.
    Aoki J; Serruys PW; van Beusekom H; Ong AT; McFadden EP; Sianos G; van der Giessen WJ; Regar E; de Feyter PJ; Davis HR; Rowland S; Kutryk MJ
    J Am Coll Cardiol; 2005 May; 45(10):1574-9. PubMed ID: 15893169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis.
    Lev EI; Leshem-Lev D; Mager A; Vaknin-Assa H; Harel N; Zimra Y; Bental T; Greenberg G; Dvir D; Solodky A; Assali A; Battler A; Kornowski R
    Eur Heart J; 2010 Nov; 31(21):2625-32. PubMed ID: 20543191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
    Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial progenitor cells and in-stent restenosis: friend, foe, or none of the above?
    Hibbert B; O'Brien ER
    Can J Cardiol; 2014 Jan; 30(1):6-7. PubMed ID: 24290519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
    Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent.
    Klomp M; Beijk MA; Damman P; Woudstra P; Koch KT; Tijssen JG; de Winter RJ
    J Interv Cardiol; 2011 Oct; 24(5):442-9. PubMed ID: 22004602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of endothelial progenitor capture cell stent during percutaneous treatment of coronary bifurcations: a prospective angiographic registry.
    Rognoni A; Secco GG; Lupi A; Santagostino M; Sansa M; Bongo AS; Rognoni G
    Crit Pathw Cardiol; 2011 Dec; 10(4):189-92. PubMed ID: 22089276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of CD34+ KDR+ endothelial progenitor cells predicts target lesion revascularization.
    Bonello L; Harhouri K; Baumstarck K; Arnaud L; Lesavre N; Piot C; Paganelli F; Dignat-George F; Sabatier F
    J Thromb Haemost; 2012 Sep; 10(9):1906-13. PubMed ID: 22805118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of EPC capture stent and CD34+ mobilization in acute myocardial infarction.
    Scacciatella P; D'Amico M; Pennone M; Conrotto F; Meliga E; Usmiani T; Meynet I; Gunetti M; Ferrero I; Rustichelli D; Fagioli F; Marra S
    Minerva Cardioangiol; 2013 Apr; 61(2):211-9. PubMed ID: 23492604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.